Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2012
09/05/2012CN1684707B Mucosal combination vaccines for bacterial meningitis
09/05/2012CN1679934B Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
09/05/2012CN1639569B Methods and compositions for inducing an immune response
09/05/2012CN1528791B Specific monoclonal antibody against epitope of clygoprotein coding inactivated feline immunodeficiency virus
09/05/2012CN1520424B Immunoglobulins 2
09/05/2012CN102656271A Generation of a broad T-cell response in humans against HIV
09/05/2012CN102656190A Monoclonal antibodies against the RGM A protein for use in the treatment of retinal nerve fiber layer degeneration
09/05/2012CN102656189A Antibodies against human respiratory syncytial virus (RSV) and methods of use
09/05/2012CN102656188A T-cell receptor capable of recognising an antigen from cytomegalovirus
09/05/2012CN102655880A IL-1 binding proteins
09/05/2012CN102655879A Vaccine composition
09/05/2012CN102655878A Supralingual vaccines and applicators
09/05/2012CN102655871A Infectious clones of Torque teno virus
09/05/2012CN102655853A Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
09/05/2012CN102653731A Recombined infectious bovine rhinotracheitis virus with deletion of gG, TK and gE genes
09/05/2012CN102653723A Yeast surface display of prawn white spot syndrome virus VP28 and application
09/05/2012CN102653565A Method for purifying capsular polysaccharide from capsular bacterium fermentation liquid
09/05/2012CN102653559A Integrin alphaiibbeta3 specific antibodies and peptides
09/05/2012CN102653554A Functional mycobacterium tuberculosis antigen polypeptide and application thereof
09/05/2012CN102652832A Treatment of multiple sclerosis (ms) with campath-1h
09/05/2012CN102652831A Immunology treatment for biofilms
09/05/2012CN102085370B Oral spray for inflammatory diseases of oral cavity and preparation method thereof
09/05/2012CN102018957B Production method of hog cholera live vaccine
09/05/2012CN101951928B Use of poly-gamma-glutamic acid in preparing composition for improving cellular immunity
09/05/2012CN101947318B Method for preparing porcine parvovirus inactivated vaccines
09/05/2012CN101914463B Proteus vulgaris (mannose-sensitive hemagglutination) piliated strain
09/05/2012CN101906404B Avian infectious bronchitis virus (IBV) as well as culture method and application thereof
09/05/2012CN101905020B Method for producing swine fever vaccines
09/05/2012CN101838318B Anti-HIV-I polypeptide and coding sequence and use thereof
09/05/2012CN101838313B Mimic short peptide 9B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/05/2012CN101838312B Mimic short peptide 12B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/05/2012CN101816789B Lyophilized viper antivenin and preparation method thereof
09/05/2012CN101816786B Inactivated hepatitis A vaccine and preparation method thereof
09/05/2012CN101775399B Asia1 type multi-epitope recombinant vaccine of bovine foot-and-mouth disease viruses and preparation method thereof
09/05/2012CN101745108B Avian influenza vaccine and preparation method thereof
09/05/2012CN101717754B Enterovirus type 71 and use thereof
09/05/2012CN101693890B Immunostimulatory sequence oligonucleotides and methods of using the same
09/05/2012CN101633907B Amplification culture method for antigen specific cytotoxic t lymphocytes
09/05/2012CN101497877B Influenza all-virus attenuated live vaccine recombinant, construction method and use thereof
09/05/2012CN101497660B Strongylus duodenalis anticoagulant peptide, as well as preparation and use thereof
09/05/2012CN101487010B Method for preparing vaccine for anti-HPV 18 infection by pichia yeast expression system
09/05/2012CN101468201B Preparation of Mycobacterium tuberculosis polyvalent recombinant protein vaccine
09/05/2012CN101460627B Process for producing poxviruses and poxvirus compositions
09/05/2012CN101437501B Prolongation of survival of an allograft by inhibiting complement activity
09/05/2012CN101389349B Educated nkt cells and their uses in the treatment of immune-related disorders
09/05/2012CN101342148B Quick-effective antimicrobial, anti-inflammation, antiviral hyperconcentrated natural allicin tablet and preparation method thereof
09/05/2012CN101257920B Methods and compositions relating to a vaccine against prostate cancer
09/05/2012CN101203607B Anti-CD-20 monoclonal antibody
09/05/2012CN101166759B T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
09/05/2012CN101048178B Combination of a recombinant mycobacterium and a biologically active agent as a vaccine
09/05/2012CN101031584B Domains and epitopes of meningococcal protein nmb1870
09/05/2012CN101014613B Chimpanzee adenovirus vaccine carriers
09/05/2012CN101001645B Il-17 antagonistic antibodies
09/04/2012US8258275 Immunogen platform
09/04/2012US8258268 Dual variable domain immunoglobulin and uses thereof
09/04/2012US8258267 Human anti-IP-10 antibodies uses thereof
09/04/2012US8258266 IP-10 antibodies and their uses
09/04/2012US8258263 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
09/04/2012US8258261 Induction of tumor immunity by variants of folate binding protein
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8257927 Hereditary hemochromatosis gene
09/04/2012US8257734 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions
09/04/2012US8257717 Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
09/04/2012US8257716 Anti-PDEF antibodies and uses thereof
09/04/2012US8257715 Tissue vaccines and uses thereof
09/04/2012US8257714 Compositions and methods for immunotherapy of cancer and infectious diseases
09/04/2012US8257713 Vaccine
09/04/2012US8257712 Virus-expressing host costimulation molecules
09/04/2012US8257711 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
09/04/2012US8257710 Method for the treatment of pain with humanized anti-nerve growth factor antibodies
09/04/2012US8257709 Antibodies against Clostridium difficile toxins and uses thereof
09/04/2012US8257708 Antibodies against cancer antigen TMEFF2 and uses thereof
09/04/2012US8257707 IL-18 receptor antigen binding proteins
09/04/2012US8257706 CD30 binding agents and uses thereof
09/04/2012US8257705 Immunoglobulin for use in treatment of inflammation, wound repair and tissue modeling
09/04/2012US8257704 Anti-sclerostin antibodies
09/04/2012US8257703 Anti-ganglioside antibodies and compositions
09/04/2012US8257702 Compositions with hematopoietic and immune activity
09/04/2012US8257701 Methods for anti-fibrinolytic treatment using MMP-10 neutralizing antibody
09/04/2012CA2674028C Recombinant b. pseudomallei adhesin protein and methods and uses thereof
09/04/2012CA2541834C Modified whole cell, cell extract and omv-based vaccines
09/04/2012CA2523084C Tuberculosis vaccine with improved efficacy
09/04/2012CA2520279C Mutant vesicular stomatitis viruses and use thereof
09/04/2012CA2491457C Iscom preparation and use thereof
09/04/2012CA2432971C Polypeptides
09/04/2012CA2414339C Bvdv virus-like particles
09/04/2012CA2384437C Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
08/2012
08/30/2012WO2012116317A2 Combination therapies comprising anti-erbb3 agents
08/30/2012WO2012116282A2 Protein nanocarriers for topical delivery
08/30/2012WO2012116280A2 Formulations useful for spray drying vaccines
08/30/2012WO2012116264A1 Biomarkers for seizures
08/30/2012WO2012116225A2 Muc1 based glycolipopeptide vaccine with adjuvant
08/30/2012WO2012116210A2 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus
08/30/2012WO2012116142A2 Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv
08/30/2012WO2012115980A1 Delivery of proteins using adeno-associated virus (aav) vectors
08/30/2012WO2012115904A2 Production of n- and o-sialylated tnfrii-fc fusion protein in yeast
08/30/2012WO2012115715A2 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
08/30/2012WO2012115597A1 Mycobacterium brumae cell wall extracts that can be used in therapy of superficial bladder cancers
08/30/2012WO2012115474A2 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same
08/30/2012WO2012115437A2 Pharmaceutical composition for cancer treatment or metastasis inhibition containing expression or activation inhibitors of map7d2 protein, novel cancer therapeutic target
1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 1823